• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 中的肺 T 细胞反应。

Lung T cell response in COVID-19.

机构信息

Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Bonn, Germany.

Immunogenomics and Neurodegeneration, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Bonn, Germany.

出版信息

Front Immunol. 2023 Feb 16;14:1108716. doi: 10.3389/fimmu.2023.1108716. eCollection 2023.

DOI:10.3389/fimmu.2023.1108716
PMID:36875071
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9977798/
Abstract

The COVID-19 pandemic has shown the potentially devastating impact of novel respiratory infections worldwide. Insightful data obtained in the last years have shed light on the pathophysiology of SARS-CoV-2 infection and the role of the inflammatory response in driving both the resolution of the disease and uncontrolled deleterious inflammatory status in severe cases. In this mini-review, we cover some important aspects of the role of T cells in COVID-19 with a special focus on the local response in the lung. We focus on the reported T cell phenotypes in mild, moderate, and severe COVID-19, focusing on lung inflammation and on both the protective and damaging roles of the T cell response, also highlighting the open questions in the field.

摘要

新冠疫情表明,新型呼吸道感染可能在全球范围内造成破坏性影响。过去几年获得的有见地的数据揭示了 SARS-CoV-2 感染的病理生理学机制,以及炎症反应在驱动疾病消退和重症病例中失控性有害炎症状态中的作用。在这篇简评中,我们将介绍 T 细胞在 COVID-19 中的作用的一些重要方面,特别关注肺部的局部反应。我们重点介绍了在轻症、中症和重症 COVID-19 中报告的 T 细胞表型,聚焦于肺部炎症以及 T 细胞反应的保护和损伤作用,并突出了该领域的悬而未决的问题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35dc/9977798/b4b4469be97d/fimmu-14-1108716-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35dc/9977798/2c51f6e3b4b4/fimmu-14-1108716-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35dc/9977798/b4b4469be97d/fimmu-14-1108716-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35dc/9977798/2c51f6e3b4b4/fimmu-14-1108716-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35dc/9977798/b4b4469be97d/fimmu-14-1108716-g002.jpg

相似文献

1
Lung T cell response in COVID-19.COVID-19 中的肺 T 细胞反应。
Front Immunol. 2023 Feb 16;14:1108716. doi: 10.3389/fimmu.2023.1108716. eCollection 2023.
2
SARS-CoV-2 activates lung epithelial cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients.SARS-CoV-2 激活肺上皮细胞促炎信号,导致 COVID-19 患者免疫失调。
EBioMedicine. 2021 Aug;70:103500. doi: 10.1016/j.ebiom.2021.103500. Epub 2021 Jul 23.
3
Recovery scenario and immunity in COVID-19 disease: A new strategy to predict the potential of reinfection.COVID-19 疾病的恢复情况和免疫:预测再次感染潜力的新策略。
J Adv Res. 2021 Jul;31:49-60. doi: 10.1016/j.jare.2020.12.013. Epub 2021 Jan 5.
4
T-cell responses and therapies against SARS-CoV-2 infection.T 细胞应答与针对 SARS-CoV-2 感染的治疗方法。
Immunology. 2021 Jan;162(1):30-43. doi: 10.1111/imm.13262. Epub 2020 Oct 27.
5
Profiling of T Cell Repertoire in SARS-CoV-2-Infected COVID-19 Patients Between Mild Disease and Pneumonia.SARS-CoV-2 感染 COVID-19 患者轻症与肺炎患者 T 细胞受体谱分析。
J Clin Immunol. 2021 Aug;41(6):1131-1145. doi: 10.1007/s10875-021-01045-z. Epub 2021 May 5.
6
Robust Virus-Specific Adaptive Immunity in COVID-19 Patients with SARS-CoV-2 Δ382 Variant Infection.COVID-19 患者感染 SARS-CoV-2 Δ382 变异株后具有强大的病毒特异性适应性免疫。
J Clin Immunol. 2022 Feb;42(2):214-229. doi: 10.1007/s10875-021-01142-z. Epub 2021 Oct 30.
7
Human Nasal and Lung Tissues Infected with SARS-CoV-2 Provide Insights into Differential Tissue-Specific and Virus-Specific Innate Immune Responses in the Upper and Lower Respiratory Tract.人鼻腔和肺部组织感染 SARS-CoV-2 提供了在上呼吸道和下呼吸道中不同组织特异性和病毒特异性先天免疫反应的见解。
J Virol. 2021 Jun 24;95(14):e0013021. doi: 10.1128/JVI.00130-21.
8
mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status.mRNA 疫苗诱导的 T 细胞对 SARS-CoV-2 关切变异株的反应完全相同,但根据先前的感染状态,其持久性和归巢特性存在差异。
Elife. 2021 Oct 12;10:e72619. doi: 10.7554/eLife.72619.
9
T-Cell Epitope Mapping of SARS-CoV-2 Reveals Coordinated IFN-γ Production and Clonal Expansion of T Cells Facilitates Recovery from COVID-19.SARS-CoV-2 的 T 细胞表位作图显示,IFN-γ 的协调产生和 T 细胞的克隆扩增有助于从 COVID-19 中恢复。
Viruses. 2024 Jun 22;16(7):1006. doi: 10.3390/v16071006.
10
Innate Immune Signaling and Proteolytic Pathways in the Resolution or Exacerbation of SARS-CoV-2 in Covid-19: Key Therapeutic Targets?固有免疫信号和蛋白水解途径在新冠病毒 2 型(SARS-CoV-2)引起的新冠肺炎(Covid-19)中的转归或恶化:关键治疗靶点?
Front Immunol. 2020 May 28;11:1229. doi: 10.3389/fimmu.2020.01229. eCollection 2020.

引用本文的文献

1
Cellular and immune response in fatal COVID-19 pneumonia.致命性新冠肺炎肺炎中的细胞和免疫反应。
Pan Afr Med J. 2024 Dec 19;49:130. doi: 10.11604/pamj.2024.49.130.45739. eCollection 2024.
2
Pulmonary Myeloid Cells in Mild Cases of COVID-19 Upregulate the Intracellular Fc Receptor and Transcribe Proteasome-Associated Molecules.新冠轻症病例中的肺髓样细胞上调细胞内Fc受体并转录蛋白酶体相关分子。
Int J Mol Sci. 2025 Mar 19;26(6):2769. doi: 10.3390/ijms26062769.
3
Mixed lipopeptide-based mucosal vaccine candidate induces cross-variant immunity and protects against SARS-CoV-2 infection in hamsters.

本文引用的文献

1
Signs of immunosenescence correlate with poor outcome of mRNA COVID-19 vaccination in older adults.免疫衰老的迹象与老年人 mRNA COVID-19 疫苗接种效果不佳相关。
Nat Aging. 2022 Oct;2(10):896-905. doi: 10.1038/s43587-022-00292-y. Epub 2022 Oct 14.
2
A guide to systems-level immunomics.系统免疫组学指南。
Nat Immunol. 2022 Oct;23(10):1412-1423. doi: 10.1038/s41590-022-01309-9. Epub 2022 Sep 22.
3
SARS-CoV-2-reactive IFN-γ-producing CD4 and CD8 T cells in blood do not correlate with clinical severity in unvaccinated critically ill COVID-19 patients.
基于混合脂肽的黏膜疫苗候选物可诱导交叉变异免疫并保护仓鼠免受SARS-CoV-2感染。
Immunohorizons. 2025 Jan 24;9(2). doi: 10.1093/immhor/vlae011.
4
Cytokine production in an model of SARS-CoV-2 lung infection.SARS-CoV-2 肺部感染模型中的细胞因子产生。
Front Immunol. 2024 Oct 21;15:1448515. doi: 10.3389/fimmu.2024.1448515. eCollection 2024.
5
Addressing Post-Acute COVID-19 Syndrome in Cancer Patients, from Visceral Obesity and Myosteatosis to Systemic Inflammation: Implications in Cardio-Onco-Metabolism.应对癌症患者的新冠后急性综合征,从内脏肥胖和肌少脂变到全身炎症:对心脏肿瘤代谢的影响
Biomedicines. 2024 Jul 24;12(8):1650. doi: 10.3390/biomedicines12081650.
6
Single MVA-SARS-2-ST/N Vaccination Rapidly Protects K18-hACE2 Mice against a Lethal SARS-CoV-2 Challenge Infection.单次 MVA-SARS-2-ST/N 疫苗接种可迅速保护 K18-hACE2 小鼠免受致死性 SARS-CoV-2 挑战感染。
Viruses. 2024 Mar 8;16(3):417. doi: 10.3390/v16030417.
7
Successful salvage of a severe COVID-19 patient previously with lung cancer and radiation pneumonitis by mesenchymal stem cells: a case report and literature review.间充质干细胞成功挽救 1 例肺癌和放射性肺炎合并 COVID-19 患者:1 例病例报告和文献复习。
Front Immunol. 2024 Feb 6;15:1321236. doi: 10.3389/fimmu.2024.1321236. eCollection 2024.
8
Low pre-existing endemic human coronavirus (HCoV-NL63)-specific T cell frequencies are associated with impaired SARS-CoV-2-specific T cell responses in people living with HIV.低水平的既往人冠状病毒(HCoV-NL63)特异性 T 细胞频率与 HIV 感染者的 SARS-CoV-2 特异性 T 细胞反应受损相关。
Front Immunol. 2024 Jan 26;14:1291048. doi: 10.3389/fimmu.2023.1291048. eCollection 2023.
血液中 SARS-CoV-2 反应性 IFN-γ 产生的 CD4 和 CD8 T 细胞与未接种疫苗的危重症 COVID-19 患者的临床严重程度无关。
Sci Rep. 2022 Aug 22;12(1):14271. doi: 10.1038/s41598-022-18659-x.
4
SARS-COV-2 Variants: Differences and Potential of Immune Evasion.SARS-CoV-2 变异株:免疫逃逸的差异和潜力。
Front Cell Infect Microbiol. 2022 Jan 18;11:781429. doi: 10.3389/fcimb.2021.781429. eCollection 2021.
5
Complement activation induces excessive T cell cytotoxicity in severe COVID-19.补体激活可导致重症 COVID-19 中 T 细胞过度细胞毒性。
Cell. 2022 Feb 3;185(3):493-512.e25. doi: 10.1016/j.cell.2021.12.040. Epub 2021 Dec 28.
6
Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection.初次感染 SARS-CoV-2 后,免疫功能障碍持续 8 个月。
Nat Immunol. 2022 Feb;23(2):210-216. doi: 10.1038/s41590-021-01113-x. Epub 2022 Jan 13.
7
Multi-omics approach to COVID-19: a domain-based literature review.多组学方法在 COVID-19 中的应用:基于领域的文献综述。
J Transl Med. 2021 Dec 7;19(1):501. doi: 10.1186/s12967-021-03168-8.
8
Post-mortem lung tissue: the fossil record of the pathophysiology and immunopathology of severe COVID-19.死后肺组织:严重 COVID-19 的病理生理学和免疫病理学的化石记录。
Lancet Respir Med. 2022 Jan;10(1):95-106. doi: 10.1016/S2213-2600(21)00408-2. Epub 2021 Dec 3.
9
Adaptive immune determinants of viral clearance and protection in mouse models of SARS-CoV-2.SARS-CoV-2 小鼠模型中病毒清除和保护的适应性免疫决定因素。
Sci Immunol. 2021 Oct 15;6(64):eabl4509. doi: 10.1126/sciimmunol.abl4509. Epub 2021 Sep 2.
10
Characterising long COVID: a living systematic review.描述长新冠:一项正在进行的系统综述。
BMJ Glob Health. 2021 Sep;6(9). doi: 10.1136/bmjgh-2021-005427.